Showing 1 - 5 results of 5 for search 'J. M. Burke', query time: 0.83s
Refine Results
-
1
PB2146: A PHASE 2, OPEN-LABEL STUDY OF LONCASTUXIMAB TESIRINE IN COMBINATION WITH RITUXIMAB (LONCA-R) IN PREVIOUSLY UNTREATED UNFIT/FRAIL PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOM... by J. Westin, J. M. Burke, A. E. Chapman, T. Kilavuz, C. Xu, Y. Shmuely, J. Radford
Published 2022-06-01
Article -
2
PB2109: REALMIND: A PROSPECTIVE, MULTICENTER, OBSERVATIONAL STUDY OF PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA STARTING SECOND/THIRD-LINE THERAPY AND NOT RECE... by C. R. Flowers, J. M. Burke, M. Vukcevic, S. Snodgrass, K. Saverno, M. A. A. Lumiqued
Published 2022-06-01
Article -
3
P1062: A REAL-WORLD EVALUATION OF THE ASSOCIATION BETWEEN ELEVATED BLOOD COUNTS AND THROMBOTIC EVENTS IN POLYCYTHEMIA VERA: AN ANALYSIS OF DATA FROM THE REVEAL STUDY by A. T. Gerds, R. Mesa, J. M. Burke, M. R. Grunwald, R. Scherber, J. Yu, J. Hamer-Maansson, S. T. Oh
Published 2022-06-01
Article -
4
PB2113: FRONTMIND: A PHASE III, RANDOMIZED, DOUBLE-BLIND STUDY OF TAFASITAMAB + LENALIDOMIDE + R-CHOP VS R-CHOP ALONE FOR NEWLY DIAGNOSED HIGH-INTERMEDIATE AND HIGH-RISK DIFFUSE LA... by U. Vitolo, G. S. Nowakowski, J. M. Burke, C. P. Fox, M. Trneny, A. Chiappella, M. Waldron-Lynch, N. Hadar, A. Pachori, G. Lenz
Published 2022-06-01
Article -
5
P1089: BRENTUXIMAB VEDOTIN, NIVOLUMAB, DOXORUBICIN, AND DACARBAZINE (AN+AD) FOR ADVANCED STAGE CLASSIC HODGKIN LYMPHOMA: PRELIMINARY SAFETY AND EFFICACY RESULTS FROM THE PHASE 2 ST... by H. Lee, I. W. Flinn, J. Melear, R. Ramchandren, J. Friedman, J. M. Burke, Y. Linhares, M. Raval, R. Chintapatla, T. A. Feldman, H. Yimer, M. Islas-Ohlmayer, A. Dean, V. Rana, M. D. Gandhi, J. Renshaw, A. L. Gillespie-Twardy, L. Ho, M. Puhlmann, W. Guo, C. A. Yasenchak
Published 2022-06-01
Article